Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Setmelanotide
Related studies linked through entity extraction aliases.
A Study of Setmelanotide in Patients With Prader-Willi Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
- Status
- RECRUITING
- Phase
- PHASE3
Open-Label Extension Study of Setmelanotide
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE4
Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity
- Status
- COMPLETED
- Phase
- PHASE3
DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway
- Status
- COMPLETED
- Phase
- PHASE2
Open-Label Study of Setmelanotide in Hypothalamic Obesity
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity
- Status
- COMPLETED
- Phase
- PHASE3
Long Term Extension Trial of Setmelanotide
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity
- Status
- COMPLETED
- Phase
- PHASE3
Setmelanotide in a Single Patient With Partial Lipodystrophy
- Status
- COMPLETED
- Phase
- PHASE2
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity
- Status
- COMPLETED
- Phase
- PHASE2
Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity
- Status
- COMPLETED
- Phase
- PHASE3
Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants
- Status
- COMPLETED
- Phase
- PHASE2